Zonegran - MSN Newsfeeds

Switching to generic drugs may be dangerous for epilepsy patients
KTRK - Neave was out of Zonegran and took the generic. "She started having lots of breakthrough seizures," said Karl. "It was a very bad month in June. She had over 20 a day." Here's a surprise: generics are not the same strength as the original drug ...
Preventive, Abortive, and Rescue Medications - What's the Difference?
HealthCentral.com - ... such as Effexor MAOI antidepressants such as Nardil Cox-2 Enzyme Inhibitors such as Celebrex Muscle relaxants such as Soma and Zanaflex Neuronal stabilizing agents (anticonvulsants) such as Keppra and Zonegran Leukotriene Blockers such as Singulair and ...
Epilepsy Drug Helps Parkinson's
HealthCentral.com - In a recent study in Japan, researchers studied 279 Parkinson's disease patients who weren't responding to levodopa, a common Parkinson's disease treatment. Patients were given doses of 25, 50 or 100 milligrams of zonisamide or a placebo each day ...
Zonisamide improves tremors, involuntary movements in Parkinson ...
Xagena Medical News - The patients were divided into groups that took 25, 50 or 100 mg a day of the drug Zonisamide ( Zonegran ) or placebo. Researchers found at least 30 percent of patients taking Zonisamide experienced a more than 30-percent reduction in their score on a ...
Chinese Missile Test Not Meant as Threat, U.S. Says (Update1)
Bloomberg - Jan. 23 (Bloomberg) -- The Chinese government assured the U.S. that the test firing of a missile into space to destroy one of its own orbiting weather satellites was ``not meant as a threat,'' the State Department said. Assistant Secretary of State ...
Epilepsy drug improves Parkinson's symptoms
Health and Age.com - Zonisamide, which is used to treat epilepsy, is also found to be effective in Parkinson's disease. Levodopa is the usual treatment for the tremor and other movement abnormalities that occur in Parkinson's disease. However, not all patients respond to ...
RPT-Schwarz Pharma says epilepsy drug reduces seizures
Reuters - We believe our efficacy is on par with competitors and lacosamide has advantages as far as side effects," Davis said, noting that drugs like Johnson & Johnson's (JNJ.N: Quote , Profile , Research ) Topamax and Zonegran, sold by Dainippon ...
Eisai Recieves Positive Opinion for Inovelon(R) Marketing ...
JCN Newswire - Eisai is currently enhancing its neurology franchise which includes Aricept(R)(donepezil) for treatment of Alzheimer's disease and anti-epilepsy agent Zonegran(R)(zonisamide). Through these activities the company expects to make further contributions ...
Cadila gets USFDA nod for Zonisamide Capsules
New Kerala - Mumbai, Oct 17: Cadila Healthcare Ltd today said it has received approval from the USFDA to market anti-epileptic drug Zonisamide Capsules. In a filing on the Bombay Stock Exchange the company said it had received approval for marketing the capsules ...
Orexigen Reports Positive Phase II Results For Excalia Combination ...
Medical News Today - Excalia is a proprietary combination of bupropion, a dopamine and norepinephrine reuptake inhibitor, plus zonisamide, an approved anticonvulsant medication. OREXIGEN's preclinical research suggests that combining these two central nervous system ...
Losses widen, sales dip at Elan
Boston Globe - ... to several exceptional factors: a US$15 million (euro12 million) licensing payment to a research partner; temporary supply problems for its injected antibiotic Maxipime; the US$23 million (euro18.3 million) sale in 2005 of a drug called Zonegran; and ...
Losses widen, sales dip at Elan despite rollout of key MS drug Tysabri
WBBM - ... quarter losses to several exceptional factors: a $15 million (euro12 million) licensing payment to a research partner; an execeptional gain in the previous quarter thanks to the $23 million (euro18.3 million) sale in 2005 of a drug called Zonegran ...
Elan Reports Third Quarter 2006 Financial Results
Genetic Engineering News - The increase in net loss is principally due to a gain of $23.0 million on the sale of Zonegran(TM) in 2005, the inclusion of share-based compensation expense of $10.9 million in 2006 for the first time, and a $15.0 million license fee payable to ...
OREXIGEN(TM) Therapeutics Reports Positive Phase II Results for ...
WAFF - Excalia is a proprietary combination of bupropion, a dopamine and norepinephrine reuptake inhibitor, plus zonisamide, an approved anticonvulsant medication. OREXIGEN's preclinical research suggests that combining these two central nervous system ...
Obesity researchers study drug cocktails
Boston Online - In a separate study, scientists used two other drugs: bupropion, typically prescribed to treat depression and to help people stop smoking, and zonisamide, which is used to treat seizures. The study participants who took both drugs lost, on average ...
OREXIGEN(TM) Therapeutics Reports Positive Phase II Results for ...
Earthtimes - Excalia is a proprietary combination of bupropion, a dopamine and norepinephrine reuptake inhibitor, plus zonisamide, an approved anticonvulsant medication. OREXIGEN's preclinical research suggests that combining these two central nervous system ...
Zydus Cadila gets nod for Zonisamide Capsules from US FDA
NetIndia123.com - Cadila Healthcare Ltd today announced it has received approval from the US FDA to market Zonisamide Capsules in different strengths of 25 mg, 50 mg and 100 mg. Announcing this in a notice to BSE, the company said the drug falls in the anti-epileptic ...
Charges possible in fatal collision
AZCentral.com - Field sobriety tests proved Kandas was not impaired with alcohol or dangerous drugs, though Kandas told DPS he has been taking a prescription drug called Zonegran, which is used to prevent epileptic seizures, for more than eight months. He said the ...
Glenmark gets US FDA nod to market generic Gabapentin
Business Standard - Gabapentin is the fourth ANDA filed by Glenmark from the Goa facility to receive US FDA approval after Fluconazole, Zonisamide and Meloxicam. With this approval, Glenmark will have ten generics on the market including two controlled substances ...
To Print: Click your browser's PRINT button.
Medscape News - ... tiagabine, and OCBZ, appear to be better tolerated than DPH, CBZ, and VPA, and their toxicity profiles in neuropsychological tests tend to be benign. [24,26] The only new AEDs that possess significant negative cognitive effects are TPM and zonisamide ...

These articles are related to: Zonegran Claim, Zonegran Lawsuit, Zonegran Law Suit, Zonegran Law Firm, Zonegran Lawyer, Zonegran Attorney, Zonegran Side Effects Symptoms, Zonegran Trial, Zonegran Verdict, Zonegran News, Zonegran Information, Zonegran Recall Lawyers, Zonegran Warning, Zonegran Class Action, Zonegran Prescription Drug, Zonegran Medication, Zonegran Drugs, Zonisamide Claim, Zonisamide Lawsuit, Zonisamide Law Suit, Zonisamide Law Firm, Zonisamide Lawyer, Zonisamide Attorney, Zonisamide Side Effects Symptoms, Zonisamide Trial, Zonisamide Verdict, Zonisamide News, Zonisamide Information, Zonisamide Recall Lawyers, Zonisamide Warning, Zonisamide Class Action, Zonisamide Prescription Drug, Zonisamide Medication, Zonisamide Drugs

AddThis Social Bookmark Button

Need A Zonegran Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Click to Ask a Question


Need A Zonegran Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Click to Ask a Question